A multicenter phase II study of erlotinib and bevacizumab in patients with metastatic melanoma
Year: 2007
Type: conference-abstract
Source: Journal of Clinical Oncology
Institutions: Sarah Cannon, Vanderbilt University Medical Center
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3010441993
